Hyperbilirubinemia and management of breastfeeding

Area of Science:

• Neonatal Medicine
• Pediatrics
• Lactation Studies

Background:

• Neonatal hyperbilirubinemia and jaundice are common physiological occurrences within specific limits.
• The highest incidence of jaundice in breastfed infants is often linked to suboptimal breastfeeding practices rather than direct effects of breast milk.
• Visible jaundice persisting beyond two weeks, termed "breast milk jaundice," does not necessitate breastfeeding cessation.

Purpose of the Study:

• To review the literature on the role of breast milk in neonatal jaundice.
• To evaluate current guidelines for hyperbilirubinemia detection and management.
• To clarify the relationship between breastfeeding and neonatal jaundice, emphasizing appropriate management strategies.

Main Methods:

• Literature review of studies and guidelines concerning neonatal hyperbilirubinemia and jaundice.
• Analysis of the etiological factors contributing to early and late-onset jaundice in breastfed neonates.
• Evaluation of diagnostic and management protocols, including the role of breastfeeding interruption.

Main Results:

• Breast milk's direct role in early and severe late jaundice has been re-evaluated.
• Inadequate breastfeeding management is a primary factor in neonatal jaundice, not typically the breast milk itself.
• Breastfeeding interruption is no longer recommended for diagnosing breast milk jaundice due to low specificity and risks.

Conclusions:

• Effective prevention of severe early-onset jaundice involves preventing poorly managed breastfeeding and providing early mother-infant support.
• Continued breastfeeding is crucial and should generally not be interrupted, even with visible jaundice.
• Current guidelines emphasize supportive breastfeeding practices over diagnostic interruptions for managing neonatal jaundice.